Arkolith/Insider Trading/ITRM/Form 4

Fishman Corey N.

Chief Executive Officer, DirectorIterum Therapeutics plc (ITRM) · full profile →Form 4 · filed Mar 14, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 11, 2023Tax withholding(F)6K$0.96$5K44K
Mar 11, 2023Grant(A)14K—$050K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 11, 2023Option exercise(M)14K—$00

Transaction Codes

F
Shares withheld for taxes
A
Grant / award
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-018584) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML